{"ok":true,"entity":{"id":"biomerieux","name":"bioMérieux SA","entityType":"company","officialName":"bioMérieux SA","canonicalName":"bioMérieux SA","displayName":"bioMérieux SA","category":"体外診断（IVD）企業","shortDescription":"フランス・ミュルシー・レトワルを拠点とする体外診断（IVD）企業で、感染症診断を中心に診断システム・試薬を提供する。ユーロネクスト・パリ上場、2025年の売上高は約41億ユーロ。2026年上期の売上高は19億6,500万ユーロ（オーガニック成長率0.2%）、CEOはPierre Boulud（2026年10月時点）。","primaryCluster":"medical-device","parentEntity":null,"verificationStatus":"draft","website":"https://www.biomerieux.com/","updatedAt":"2026-10-13T05:36:43.320Z","secondaryClusters":[],"alias":["bioMérieux","ビオメリュー"],"searchKeywords":["bioMérieux","ビオメリュー","体外診断","IVD","BIOFIRE","VIDAS","VITEK","感染症診断","ミュルシー・レトワル"]},"referenceIndex":["P-01-001","P-02-001","P-04-001","P-05-001","P-06-001"]}